EFTR Insider Trading Activity and SEC Form 4 Filings
EFTR insider trading summary
No open-market insider purchases or sales of eFFECTOR Therapeutics, Inc. (EFTR) have been reported on SEC Form 4 in the past 12 months.
Latest EFTR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 27, 2023 | SR One Capital Fund I Aggregator LP | 10% Owner | Sell | $261K (430,578 @ $0.61) |
| Nov 27, 2023 | Simeon George | 10% Owner | Sell | $261K (430,578 @ $0.61) |
| Nov 27, 2023 | Sr One Capital Partners I, LP | 10% Owner | Sell | $261K (430,578 @ $0.61) |
| Nov 27, 2023 | SR One Co-Invest I, LLC | 10% Owner | Sell | $108K (178,585 @ $0.61) |
| Nov 27, 2023 | SR One Co-Invest I, LLC | 10% Owner | Sell | $261K (430,578 @ $0.61) |
| Nov 27, 2023 | SR One Co-Invest I Manager, LLC | 10% Owner | Sell | $261K (430,578 @ $0.61) |
| Nov 27, 2023 | Sr One Capital Management, LLC | 10% Owner | Sell | $108K (178,585 @ $0.61) |
| Nov 27, 2023 | Sr One Capital Partners I, LP | 10% Owner | Sell | $108K (178,585 @ $0.61) |
| Nov 27, 2023 | SR One Capital Fund I Aggregator LP | 10% Owner | Sell | $108K (178,585 @ $0.61) |
| Nov 27, 2023 | Sr One Capital Management, LLC | 10% Owner | Sell | $261K (430,578 @ $0.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.